
Hard-shell and modified-release capsules from a GMP manufacturer, in gelatin or vegetable HPMC shells, released against the pharmacopoeial monograph on your order.

Hard-shell and modified-release capsules from a GMP manufacturer, in gelatin or vegetable HPMC shells, released against the pharmacopoeial monograph on your order.
Capsules carry several WHO Model List entries where the shell is part of the specification — fluconazole 50 mg and omeprazole are listed as capsules rather than tablets, and for some molecules the capsule shell is what protects the active substance through the stomach.
Yes. Both shell materials are available and the choice is recorded in the specification, since several markets require a stated shell origin on the dossier.
Yes — banding and sealing are agreed as part of the specification and shown on the artwork and batch record.
Delayed-release and enteric-protected presentations are produced where the molecule requires it, with the corresponding release testing in the dossier.
Every line is quoted against a written specification: monograph, strength, pack configuration, release tests and the documents that ship with the batch. Certificates of analysis, stability data and the GMP certificate accompany each consignment; dossier and registration support are provided where the market requires a filing.
Send a requirement · full product catalogue · therapeutic ranges
Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.